No Data
No Data
Neurocrine Wins FDA Nod for CAH Therapy
Weekly Buzz: Tech stocks hit high scores on ominous day
Solid Biosciences Positioned For Next-Gen Duchenne Muscular Dystrophy Treatment Success: Analyst
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
Market Mixed on Friday the 13th | Livestock
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today